1 week ago
SELLAS Life Sciences (SLS) Stock Surges 20% on Earnings Beat and Pivotal Trial Milestone
SELLAS Life Sciences (SLS) stock jumped 20% after beating Q1 estimates and announcing its Phase 3 AML trial is nearing final analysis with 78 of 80 events.
The post SELLAS Life Sciences (SLS) Stock Surges 20% on Earnings Beat and Pivotal Trial Milestone appeared first on Blockonomi.
Source: Blockonomi →Related News
- 18 hours ago
Hewlett Packard Enterprise (HPE) Stock Soars to Record Peak as Elliott Expands P...
- 18 hours ago
Norwegian Cruise Line (NCLH) Stock Plummets 9.5% — Company Insiders Buy Big
- 18 hours ago
Dell (DELL) Stock Rockets 16% to All-Time Peak Ahead of May 28 Earnings
- 18 hours ago
BlackBerry (BB) Stock Surges 19% to New 52-Week Peak on Bullish Outlook
- 18 hours ago
Navitas Semiconductor (NVTS) Stock Soars 20% as AI Power Shift Fuels Rally